Cargando…
The impact of pricing strategy on the costs of oral anti‐cancer drugs
BACKGROUND: The soaring costs of anti‐cancer drugs pose a threat to the sustainability of cancer care. The pricing strategy chosen by manufacturers can impact the costs of oral anti‐cancer drugs during dose modifications, but this issue remains under‐recognized in the literature. In general, with th...
Autores principales: | Truong, Judy, Chan, Kelvin K. W., Mai, Helen, Chambers, Alexandra, Sabharwal, Mona, Trudeau, Maureen E., Cheung, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639183/ https://www.ncbi.nlm.nih.gov/pubmed/31132223 http://dx.doi.org/10.1002/cam4.2269 |
Ejemplares similares
-
Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?
por: Cheung, Matthew C, et al.
Publicado: (2017) -
Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations
por: Jiang, Di Maria, et al.
Publicado: (2019) -
Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits
por: Parmar, Ambica, et al.
Publicado: (2019) -
Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs
por: Lee, Junsoo, et al.
Publicado: (2021) -
Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World
por: Goldstein, Daniel A., et al.
Publicado: (2016)